Brief: NeoDynamics Receives Regulatory Approval For New Breast Cancer Biopsy System
Oct 29 (Reuters) - NeoDynamics AB NEOD.TE :
* NEODYNAMICS RECEIVES REGULATORY APPROVAL FOR NEW BREAST
CANCER
BIOPSY SYSTEM
* CONFIRMATION THAT INTERTEK HAS ACCEPTED NEW IMPROVED
VERSION AS
AN UPDATE TO ALREADY EU APPROVED SYSTEM USED IN CLINICAL TRIALS
IN GERMANY, UK AND SWEDEN, ELIMINATES UNCERTAINTY AND
SIGNIFICANTLY SHORTENS TIME TO MARKET
Source text for Eikon: ID:nWkrbxBYnR
Further company coverage: NEOD.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Neodynamics AB (publ)
See all newsBrief: Neodynamics' Stock Is Delisted From Nasdaq First North
Brief: Salénterprise Ownership In NeoDynamics Rises To About 46% After Offer
Brief: NeoDynamics Intends To Apply For Delisting
Brief: Neodynamics Chooses Not To Advise Shareholders On Decision To Accept Offer From Salénterprise
Brief: Salénterprise Makes Cash Offer To Shareholders Neodynamics